Literature DB >> 28426557

Loop ileostomy versus total colectomy as surgical treatment for Clostridium difficile-associated disease: An Eastern Association for the Surgery of Trauma multicenter trial.

Paula Ferrada1, Rachael Callcut, Martin D Zielinski, Brandon Bruns, Daniel Dante Yeh, Tanya L Zakrison, Jonathan P Meizoso, Babak Sarani, Richard D Catalano, Peter Kim, Valerie Plant, Amelia Pasley, Linda A Dultz, Asad J Choudhry, Elliott R Haut.   

Abstract

OBJECTIVES: The mortality of patients with Clostridium difficile-associated disease (CDAD) requiring surgery continues to be very high. Loop ileostomy (LI) was introduced as an alternative procedure to total colectomy (TC) for CDAD by a single-center study. To date, no reproducible results have been published. The objective of this study was to compare these two procedures in a multicentric approach to help the surgeon decide what procedure is best suited for the patient in need.
METHODS: This was a retrospective multicenter study conducted under the sponsorship of the Eastern Association for the Surgery of Trauma. Demographics, medical history, clinical presentation, APACHE score, and outcomes were collected. We used the Research Electronic Data Capture tool to store the data. Mann-Whitney (continuous data) and Fisher exact (categorical data) were used to compare TC with LI. Logistic regression was performed to determine predictors of mortality. A propensity score analysis was done to control for potential confounders and determine adjusted mortality rates by procedure type.
RESULTS: We collected data from 10 centers of patients who presented with CDAD requiring surgery between July 1, 2010 and July 30, 2014. Two patients died during the surgical procedure, leaving 98 individuals in the study. The overall mortality was 32%, and 75% had postoperative complications. Median age was 64.5 years; 59% were male. Concerning preoperative patient conditions, 54% were on pressors, 47% had renal failure, and 36% had respiratory failure. When comparing TC and LI, there was no statistical difference regarding these conditions. Univariate preprocedure predictors of mortality were age, lactate, timing of operation, vasopressor use, and acute renal failure. There was no statistical difference between the APACHE score of patients undergoing either procedure (TC, 22 vs LI, 16). Adjusted mortality (controlled for preprocedure confounders) was significantly lower in the LI group (17.2% vs 39.7%; p = 0.002).
CONCLUSIONS: This is the first multicenter study comparing TC with LI for the treatment of CDAD. In this study, LI carried less mortality than TC. In patients without contraindications, LI should be considered for the surgical treatment of CDAD. LEVEL OF EVIDENCE: Therapeutic study, level III.

Entities:  

Mesh:

Year:  2017        PMID: 28426557      PMCID: PMC5998809          DOI: 10.1097/TA.0000000000001498

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  17 in total

1.  Increasing Incidence of and Increased Mortality Associated With Clostridium difficile-Associated Megacolon.

Authors:  SreyRam Kuy; Peter Jenkins; Ramon A L Romero; Navdeep Samra; SreyReath Kuy
Journal:  JAMA Surg       Date:  2016-01       Impact factor: 14.766

2.  Risk factors for the development of fulminant Clostridium difficile colitis.

Authors:  Alexander J Greenstein; John C Byrn; Linda P Zhang; Kristin A Swedish; Alice E Jahn; Celia M Divino
Journal:  Surgery       Date:  2008-03-24       Impact factor: 3.982

Review 3.  Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence.

Authors:  Konstantinos Z Vardakas; Konstantinos A Polyzos; Konstantina Patouni; Petros I Rafailidis; George Samonis; Matthew E Falagas
Journal:  Int J Antimicrob Agents       Date:  2012-03-06       Impact factor: 5.283

4.  Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated disease.

Authors:  Matthew D Neal; John C Alverdy; Daniel E Hall; Richard L Simmons; Brian S Zuckerbraun
Journal:  Ann Surg       Date:  2011-09       Impact factor: 12.969

5.  Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada.

Authors:  Jacques Pepin; Marie-Eve Alary; Louis Valiquette; Evelyne Raiche; Joannie Ruel; Katalin Fulop; Dominique Godin; Claude Bourassa
Journal:  Clin Infect Dis       Date:  2005-04-25       Impact factor: 9.079

6.  Improving mortality in trauma laparotomy through the evolution of damage control resuscitation: Analysis of 1,030 consecutive trauma laparotomies.

Authors:  Bellal Joseph; Asad Azim; Bardiya Zangbar; Zachary Bauman; Terence OʼKeeffe; Kareem Ibraheem; Narong Kulvatunyou; Andrew Tang; Riaft Latifi; Peter Rhee
Journal:  J Trauma Acute Care Surg       Date:  2017-02       Impact factor: 3.313

7.  Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.

Authors:  Jacques Pépin; Louis Valiquette; Marie-Eve Alary; Philippe Villemure; Annick Pelletier; Karine Forget; Karine Pépin; Daniel Chouinard
Journal:  CMAJ       Date:  2004-08-31       Impact factor: 8.262

8.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

Authors:  J G Bartlett; T W Chang; M Gurwith; S L Gorbach; A B Onderdonk
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

9.  An institutional comparison of total abdominal colectomy and diverting loop ileostomy and colonic lavage in the treatment of severe, complicated Clostridium difficile infections.

Authors:  Anna Z Fashandi; Allison N Martin; Patty T Wang; Traci L Hedrick; Charles M Friel; Philip W Smith; R Ann Hays; Peter T Hallowell
Journal:  Am J Surg       Date:  2016-11-23       Impact factor: 2.565

10.  Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy.

Authors:  Mark A Miller; Thomas Louie; Kathleen Mullane; Karl Weiss; Arnold Lentnek; Yoav Golan; Yin Kean; Pam Sears
Journal:  BMC Infect Dis       Date:  2013-03-25       Impact factor: 3.090

View more
  9 in total

1.  Evolving Strategies to Manage Clostridium difficile Colitis.

Authors:  Jessica A Bowman; Garth H Utter
Journal:  J Gastrointest Surg       Date:  2019-11-25       Impact factor: 3.452

2.  Faecal microbiota transplant decreases mortality in severe and fulminant Clostridioides difficile infection in critically ill patients.

Authors:  Emily N Tixier; Elijah Verheyen; Ryan C Ungaro; Ari M Grinspan
Journal:  Aliment Pharmacol Ther       Date:  2019-10-14       Impact factor: 8.171

Review 3.  Role of Surgery in Clostridium difficile Infection.

Authors:  Aela Vely; Paula Ferrada
Journal:  Clin Colon Rectal Surg       Date:  2020-02-25

4.  Trends in Diverting Loop Ileostomy vs Total Abdominal Colectomy as Surgical Management for Clostridium difficile Colitis.

Authors:  Yen-Yi Juo; Yas Sanaiha; Ziyad Jabaji; Peyman Benharash
Journal:  JAMA Surg       Date:  2019-10-01       Impact factor: 14.766

5.  Perioperative Pain Management Issues Unique to Older Adults Undergoing Surgery: A Narrative Review.

Authors:  Adam D Shellito; Jill Q Dworsky; Patrick J Kirkland; Ronnie A Rosenthal; Catherine A Sarkisian; Clifford Y Ko; Marcia M Russell
Journal:  Ann Surg Open       Date:  2021-09

Review 6.  Diverting loop ileostomy with colonic lavage as an alternative to colectomy for fulminant Clostridioides difficile: a systematic review and meta-analysis.

Authors:  Tyler McKechnie; Yung Lee; Jeremy E Springer; Aristithes G Doumouras; Dennis Hong; Cagla Eskicioglu
Journal:  Int J Colorectal Dis       Date:  2019-11-21       Impact factor: 2.571

Review 7.  2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients.

Authors:  Massimo Sartelli; Stefano Di Bella; Lynne V McFarland; Sahil Khanna; Luis Furuya-Kanamori; Nadir Abuzeid; Fikri M Abu-Zidan; Luca Ansaloni; Goran Augustin; Miklosh Bala; Offir Ben-Ishay; Walter L Biffl; Stephen M Brecher; Adrián Camacho-Ortiz; Miguel A Caínzos; Shirley Chan; Jill R Cherry-Bukowiec; Jesse Clanton; Federico Coccolini; Maria E Cocuz; Raul Coimbra; Francesco Cortese; Yunfeng Cui; Jacek Czepiel; Zaza Demetrashvili; Isidoro Di Carlo; Salomone Di Saverio; Irina M Dumitru; Christian Eckmann; Edward H Eiland; Joseph D Forrester; Gustavo P Fraga; Jean L Frossard; Donald E Fry; Rita Galeiras; Wagih Ghnnam; Carlos A Gomes; Ewen A Griffiths; Xavier Guirao; Mohamed H Ahmed; Torsten Herzog; Jae Il Kim; Tariq Iqbal; Arda Isik; Kamal M F Itani; Francesco M Labricciosa; Yeong Y Lee; Paul Juang; Aleksandar Karamarkovic; Peter K Kim; Yoram Kluger; Ari Leppaniemi; Varut Lohsiriwat; Gustavo M Machain; Sanjay Marwah; John E Mazuski; Gokhan Metan; Ernest E Moore; Frederick A Moore; Carlos A Ordoñez; Leonardo Pagani; Nicola Petrosillo; Francisco Portela; Kemal Rasa; Miran Rems; Boris E Sakakushev; Helmut Segovia-Lohse; Gabriele Sganga; Vishal G Shelat; Patrizia Spigaglia; Pierre Tattevin; Cristian Tranà; Libor Urbánek; Jan Ulrych; Pierluigi Viale; Gian L Baiocchi; Fausto Catena
Journal:  World J Emerg Surg       Date:  2019-02-28       Impact factor: 5.469

Review 8.  Critical Care Management of the Patient with Clostridioides difficile.

Authors:  Max W Adelman; Michael H Woodworth; Virginia O Shaffer; Greg S Martin; Colleen S Kraft
Journal:  Crit Care Med       Date:  2021-01-01       Impact factor: 9.296

9.  Recommendations for the diagnosis and treatment of Clostridioides difficile infection: An official clinical practice guideline of the Spanish Society of Chemotherapy (SEQ), Spanish Society of Internal Medicine (SEMI) and the working group of Postoperative Infection of the Spanish Society of Anesthesia and Reanimation (SEDAR).

Authors:  E Bouza; J M Aguado; L Alcalá; B Almirante; P Alonso-Fernández; M Borges; J Cobo; J Guardiola; J P Horcajada; E Maseda; J Mensa; N Merchante; P Muñoz; J L Pérez Sáenz; M Pujol; E Reigadas; M Salavert; J Barberán
Journal:  Rev Esp Quimioter       Date:  2020-02-20       Impact factor: 1.553

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.